214 related articles for article (PubMed ID: 31908486)
1. Long Non-Coding RNA HOXA11-AS Promotes Non-Small Cell Lung Cancer Tumorigenesis Through microRNA-148a-3p/DNMT1 Regulatory Axis.
Bai Y; Lang L; Zhao W; Niu R
Onco Targets Ther; 2019; 12():11195-11206. PubMed ID: 31908486
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding HOXA11-AS knockdown suppresses the progression of non-small cell lung cancer by regulating miR-3619-5p/SALL4 axis.
Xia H; Niu Q; Ding Y; Zhang Z; Yuan J; Jin W
J Mol Histol; 2021 Aug; 52(4):729-740. PubMed ID: 34050851
[TBL] [Abstract][Full Text] [Related]
3. CircRNA 0009043 suppresses non-small-cell lung cancer development via targeting the miR-148a-3p/DNAJB4 axis.
She K; Yu S; He S; Wang W; Chen B
Biomark Res; 2022 Aug; 10(1):61. PubMed ID: 35974419
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of LINC00346 regulates cell migration and proliferation via competitively binding to miRNA-148a-3p/Dnmt1 in Hirschsprung's disease.
Li L; Li X; Wang X; Liu W; Wu R
Pediatr Surg Int; 2022 Sep; 38(9):1273-1281. PubMed ID: 35836014
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA HOXA11-AS regulates ischemic neuronal death by targeting miR-337-3p/YBX1 signaling pathway: protective effect of dexmedetomidine.
Yan F; Wang P; Yang X; Wang F
Aging (Albany NY); 2023 Apr; 15(7):2797-2811. PubMed ID: 37059588
[TBL] [Abstract][Full Text] [Related]
6. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
Shi J; Tan S; Song L; Song L; Wang Y
Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive analysis of the predicted targets of miR-642b-3p associated with the long non-coding RNA HOXA11-AS in NSCLC cells.
Zhang Y; Luo J; Wang X; Wang HL; Zhang XL; Gan TQ; Chen G; Luo DZ
Oncol Lett; 2018 May; 15(5):6147-6160. PubMed ID: 29616096
[TBL] [Abstract][Full Text] [Related]
8. Casticin inhibits stemness of hepatocellular carcinoma cells via disrupting the reciprocal negative regulation between DNMT1 and miR-148a-3p.
Li X; Wang L; Cao X; Zhou L; Xu C; Cui Y; Qiu Y; Cao J
Toxicol Appl Pharmacol; 2020 Jun; 396():114998. PubMed ID: 32268151
[TBL] [Abstract][Full Text] [Related]
9. LncRNA HOXA11-AS aggravates the keloid formation by targeting miR-148b-3p/IGFBP5 axis.
Wang J; Shen J
Biochem Biophys Res Commun; 2021 Dec; 581():60-67. PubMed ID: 34655977
[TBL] [Abstract][Full Text] [Related]
10. Long Non-Coding RNA HOXA11-AS Modulates Proliferation, Apoptosis, Metastasis and EMT in Cutaneous Melanoma Cells Partly via miR-152-3p/ITGA9 Axis.
Xu Y; Zhang J; Zhang Q; Xu H; Liu L
Cancer Manag Res; 2021; 13():925-939. PubMed ID: 33564267
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-148a-3p inhibits the proliferation of cervical cancer cells by regulating the expression levels of DNMT1 and UTF1.
Chen Q; Wang Y; Dang H; Wu X
Oncol Lett; 2021 Aug; 22(2):617. PubMed ID: 34257725
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA homeobox A11 antisense RNA (HOXA11-AS) promotes retinoblastoma progression via sponging miR-506-3p.
Han N; Zuo L; Chen H; Zhang C; He P; Yan H
Onco Targets Ther; 2019; 12():3509-3517. PubMed ID: 31123409
[No Abstract] [Full Text] [Related]
13. The long noncoding RNA HOXA11-AS promotes lung adenocarcinoma proliferation and glycolysis via the microRNA-148b-3p/PKM2 axis.
Chen W; Li X; Du B; Cui Y; Ma Y; Li Y
Cancer Med; 2023 Feb; 12(4):4421-4433. PubMed ID: 35924724
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
Huang Y; Ni R; Wang J; Liu Y
Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
[TBL] [Abstract][Full Text] [Related]
15. miR-148a-3p Suppresses the Proliferation and Invasion of Esophageal Cancer by Targeting DNMT1.
Wang Y; Hu Y; Guo J; Wang L
Genet Test Mol Biomarkers; 2019 Feb; 23(2):98-104. PubMed ID: 30735457
[TBL] [Abstract][Full Text] [Related]
16. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
17. Highly expressed lncRNA FOXD3-AS1 promotes non-small cell lung cancer progression via regulating miR-127-3p/mediator complex subunit 28 axis.
Zeng ZL; Zhu HK; He LF; Xu X; Xie A; Zheng EK; Ni JJ; Liu JT; Zhao GF
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2525-2538. PubMed ID: 32196603
[TBL] [Abstract][Full Text] [Related]
18. RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR-148a-3p/DNMT1 axis.
Jili S; Eryong L; Lijuan L; Chao Z
Cell Biochem Funct; 2016 Dec; 34(8):597-605. PubMed ID: 27859417
[TBL] [Abstract][Full Text] [Related]
19. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
Wang X; Li H; Shi J
Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
[TBL] [Abstract][Full Text] [Related]
20. Regulation of laryngeal squamous cell cancer progression by the lncRNA H19/miR-148a-3p/DNMT1 axis.
Wu T; Qu L; He G; Tian L; Li L; Zhou H; Jin Q; Ren J; Wang Y; Wang J; Kan X; Liu M; Shen J; Guo M; Sun Y
Oncotarget; 2016 Mar; 7(10):11553-66. PubMed ID: 26872375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
